CDC42 and metabolic disease: It was previously reported that miR-107 may be of particular importance in metabolic diseases [27], be important in regulating neural injury in cortical neurons [14], suppress esophageal squamous cell carcinoma proliferation, migration, and invasion by targeting Cdc42 [28], and inhibit myoblasts differentiation via Wnt3a [10].